nVerses Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-100
Closed -$4.24K 819
2024
Q3
$4.24K Sell
100
-3,100
-97% -$131K ﹤0.01% 939
2024
Q2
$129K Buy
3,200
+2,300
+256% +$96K 0.08% 368
2024
Q1
$31.9K Buy
+900
New +$24.1K 0.08% 338

Other funds holding TNDM

nVerses Capital's TNDM Position: Q4 2024 in Review

nVerses Capital sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 100 shares — an estimated $4.24K sold.

nVerses Capital first reported a position in TNDM in Q1 2024 and held it in 3 quarters. The position peaked at $129K in Q2 2024. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • nVerses Capital reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • nVerses Capital sold 100 Tandem Diabetes Care shares in Q4 2024, an estimated $4.24K.
  • nVerses Capital first reported a position in Tandem Diabetes Care in Q1 2024 and held it in 3 quarters.
  • nVerses Capital's Tandem Diabetes Care position peaked at $129K in Q2 2024.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.